Breaking News Instant updates and real-time market news.

WBA

Walgreens Boots Alliance

$76.95

1.12 (1.48%)

, KKR

KKR

$20.50

0.14 (0.69%)

08:44
10/06/17
10/06
08:44
10/06/17
08:44

European Commission clears acquisition of PharMerica by Walgreens, KKR

The European Commission announced it has approved, under the EU Merger Regulation, the acquisition of PharMerica (PMC) by KKR & Co. (KKR) and Walgreens Boots Alliance (WBA). The Commission concluded that the proposed acquisition would raise no competition concerns, because PharMerica has no actual or planned activities in the European Economic Area.

WBA

Walgreens Boots Alliance

$76.95

1.12 (1.48%)

KKR

KKR

$20.50

0.14 (0.69%)

PMC

PharMerica

  • 25

    Oct

  • 06

    Nov

  • 07

    Nov

WBA Walgreens Boots Alliance
$76.95

1.12 (1.48%)

10/06/17
LEER
10/06/17
NO CHANGE
LEER
Leerink convinced Amazon entering drug distribution within two years
After calls with pharmacy benefit managers and retail pharmacy specialists, Leerink analyst Ana Gupte says she's convinced that Amazon.com (AMZN) "will almost certainly" enter the drug distribution value chain within two years, evolving into a more disruptive offering over time. Amazon's move is most threatening for retail pharmacies Walgreens Boots Alliance (WAB), CVS Health (CVS) and Wal-Mart (WMT), Gupte tells investors in a research note. The analyst calls Amazon both an opportunity and threat for Express Scripts (ESRX) and views UnitedHealth (UNH) and Humana (HUM) as "largely buffered." Gupte's conversations with specialists indicate Amazon is hiring relevant talent and is in active discussions with mid-market pharmacy benefit managers and possibly even with large players such as Prime Therapeutics. It is believed Amazon will start by capturing share in both the cash paying and third party mail order and possibly specialty pharmacy segments, Gupte notes. She expects Anthem (ANTM), Aetna (AET) and Cigna (CI) will likely to contemplate Amazon's entry in their upcoming PBM contract decisions.
10/06/17
10/06/17
DOWNGRADE
Target $85

Equal Weight
Walgreens downgraded to Equal Weight from Overweight at Morgan Stanley
As previously reported, Morgan Stanley analyst Ricky Goldwasser downgraded Walgreens Boots Alliance to Equal Weight from Overweight, as he expects the company's guidance to come in below consensus estimates when it is provided later this month. The key drivers he cites are recent Part D preferred network exclusions, as well as reimbursement cuts in the U.K. and reimbursement pressure in the U.S. Goldwasser, who notes the company's growth is slowing, cut his price target on Walgreens shares to $85 from $95.
10/06/17
MSCO
10/06/17
DOWNGRADE
MSCO
Equal Weight
Walgreens Boots Alliance downgraded to Equal Weight at Morgan Stanley
10/02/17
JEFF
10/02/17
NO CHANGE
Target $95
JEFF
Buy
Walgreens growth from Rite Aid stores not priced in, says Jefferies
Jefferies analyst Brian Tanquilut says he remains positive on Walgreens Boots Alliance (WBA) given his expectation for sustained double-digit earnings growth over the next few years. The acquisition of Rite Aid (RAD) stores will yield incremental earnings growth in the next few years that's not yet priced into the stock, Tanquilut tells investors in a research note. He believes that while Amazon (AMZN) risk to front-end pharmaceutical sales "is real," Walgreens has done better than peers in "weathering the storm." The analyst has a Buy rating on the shares with a $95 price target.
KKR KKR
$20.50

0.14 (0.69%)

07/25/17
LEER
07/25/17
DOWNGRADE
Target $66.5
LEER
Market Perform
WebMD downgraded to Market Perform from Outperform at Leerink
Leerink analyst David Larsen downgraded WebMD (WBMD) to Market Perform from Outperform after the company announced that it has entered into a definitive agreement to be acquired by Internet Brands, a KKR (KKR) portfolio company, in a transaction valued at about $2.8B. The analyst also raised his price target on WebMD's shares to $66.50 from $60.
05/09/17
NEED
05/09/17
NO CHANGE
Target $16
NEED
Buy
KKR adds $5 per share to Pandora value, says Needham
Noting that Pandora (P) announced it had raised $150M by selling a 5-year, 8% convertible preferred security to KKR (KKR), Needham analyst Laura Martin calculates that adding KKR to the Pandora story adds $5 per share to the latter's value, implying that it should trade up to $15 per share on the news over time. The analyst believes KKR provides a financial safety net, and expects KKR's exit time frame to be 5 years, giving public shareholders a clearer exit path. She reiterates a Buy rating and $16 price target on Pandora's shares.
09/29/17
09/29/17
NO CHANGE

SoftBank eyes acquisitions to create $300B asset-management arm, Bloomberg says
SoftBank Group (SFTBF) is looking at further acquisitions in the financial sector in an effort to establish a $300B asset management arm that would include its $93B Vision Fund over the next four to five years, Bloomberg reports, citing people familiar with the matter. SoftBank, which agreed to acquire Fortress Investment Group (FIG) for $3.3B in February, is mulling investments in the space such as acquiring traditional investment firms or taking stakes in major private equity shops like KKR (KKR). Reference Link
08/09/17
BARD
08/09/17
NO CHANGE
BARD
Neutral
AmerisourceBergen settlement ups odds of PharMerica switch, says Baird
Baird analyst Eric Coldwell said AmerisourceBergen's (ABC) 10-Q last week showed that the company and PharMerica (PMC) have tentatively agreed to settle their long-running legal fight, which he reads as significantly increasing the odds of AmerisourceBergen displacing incumbent Cardinal Health (CAH) after KKR (KKR) and minority investor Walgreens (WBA) complete their deal to buy PharMerica. Coldwell has a Neutral rating and $89 price target on AmerisourceBergen shares.
PMC PharMerica

08/03/17
BRRR
08/03/17
DOWNGRADE
BRRR
Underperform
PharMerica downgraded to Underperform from Outperform at Barrington
Barrington analyst Michael Petusky double downgraded PharMerica (PMC) to Underperform saying other takeover bidders are unlikely to emerge. The analyst suggests redeploying proceeds into Tivity Health (TVTY), Primo Water (PRMW), U.S. Physical Therapy (USPH) and OPKO Health (OPK).
08/04/17
FBCO
08/04/17
DOWNGRADE
FBCO
Neutral
PharMerica downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Erin Wilson Wright downgraded PharMerica (PMC) to Neutral from Outperform, citing the company's agreement to be acquired by a newly formed company controlled by KKR (KKR), with Walgreens Boots Alliance (WBA) as a minority investor.
08/02/17
LEER
08/02/17
NO CHANGE
LEER
AmerisourceBergen may benefit from PharMerica takeover, says Leerink
Leerink analyst David Larsen believes AmerisourceBergen (ABC) could benefit from KKR's (KKR) buyout of PharMerica (PMC). KKR and Walgreens Boots Alliance (WBA), which uses AmerisourceBergen as a supplier, are forming a new private company which would hold PharMerica, Larsen tells investors in a research note. He believes PharMerica may switch away from its current supplier Cardinal Health (CAH) as a result of today's deal and use AmerisourceBergen. Any potential change in distributor contracts would likely occur in the second half of 2018, the analyst adds.

TODAY'S FREE FLY STORIES

SFTBF

SoftBank

$87.75

-0.305 (-0.35%)

08:51
10/19/17
10/19
08:51
10/19/17
08:51
Initiation
SoftBank initiated  »

SoftBank initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLX

Shell Midstream

$26.61

-0.44 (-1.63%)

08:50
10/19/17
10/19
08:50
10/19/17
08:50
Hot Stocks
Shell Midstream raises quarterly distribution by 4.6% to 31.8c per unit »

Shell Midstream announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

  • 16

    Nov

AGN

Allergan

$187.15

-10.63 (-5.37%)

08:50
10/19/17
10/19
08:50
10/19/17
08:50
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

BOLD

Audentes Therapeutics

$25.41

0.31 (1.24%)

08:50
10/19/17
10/19
08:50
10/19/17
08:50
Conference/Events
William Blair biotech analyst holds an analyst/industry conference call »

Biotech Analyst Prasad,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

08:50
10/19/17
10/19
08:50
10/19/17
08:50
General news
U.S. initial jobless claims dropped 22k to 222k in the October 14 week »

U.S. initial jobless…

GATX

GATX

$64.28

0.33 (0.52%)

08:48
10/19/17
10/19
08:48
10/19/17
08:48
Earnings
GATX reports Q3 EPS $1.25, consensus 97c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

ABT

Abbott

$55.77

0.71 (1.29%)

08:48
10/19/17
10/19
08:48
10/19/17
08:48
Recommendations
Abbott analyst commentary  »

Abbott price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$48.65

0.25 (0.52%)

08:47
10/19/17
10/19
08:47
10/19/17
08:47
Hot Stocks
Verizon says wireless service revenue to improve by end of 2017 »

Says balance sheet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

SGMS

Scientific Games

$42.85

0.1 (0.23%)

08:47
10/19/17
10/19
08:47
10/19/17
08:47
Hot Stocks
Scientific Games' casino management system selected by Snoqualmie Casino »

Scientific Games will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

AAOI

Applied Optoelectronics

$42.29

-1.45 (-3.32%)

, XME

SPDR S&P Metals & Mining

$32.73

0.15 (0.46%)

08:45
10/19/17
10/19
08:45
10/19/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

AAOI

Applied Optoelectronics

$42.29

-1.45 (-3.32%)

XME

SPDR S&P Metals & Mining

$32.73

0.15 (0.46%)

CBI

CB&I

$15.85

-0.19 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 16

    Nov

08:45
10/19/17
10/19
08:45
10/19/17
08:45
General news
Treasury Action: yields stabilized above lows »

Treasury Action: yields…

HRL

Hormel Foods

$31.34

-0.17 (-0.54%)

08:44
10/19/17
10/19
08:44
10/19/17
08:44
Recommendations
Hormel Foods analyst commentary  »

Hormel Foods price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$159.76

-0.71 (-0.44%)

, HNHPF

Hon Hai Precision

$7.49

0.412 (5.82%)

08:44
10/19/17
10/19
08:44
10/19/17
08:44
Periodicals
Apple, suppliers fall after report of reduced iPhone 8 orders, Bloomberg says »

Shares of Apple (AAPL)…

AAPL

Apple

$159.76

-0.71 (-0.44%)

HNHPF

Hon Hai Precision

$7.49

0.412 (5.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 02

    Nov

GALT

Galectin Therapeutics

$2.51

0.22 (9.61%)

08:44
10/19/17
10/19
08:44
10/19/17
08:44
Initiation
Galectin Therapeutics initiated  »

Galectin Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$47.52

0.51 (1.08%)

08:42
10/19/17
10/19
08:42
10/19/17
08:42
Initiation
Madrigal Pharmaceuticals initiated  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

RMBL

RumbleON

$9.30

0.3 (3.33%)

08:42
10/19/17
10/19
08:42
10/19/17
08:42
Syndicate
RumbleON 2.91M share Secondary priced at $5.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

XPO

XPO Logistics

$64.76

0.12 (0.19%)

08:40
10/19/17
10/19
08:40
10/19/17
08:40
Hot Stocks
Department of Defense boosts XPO contract by $139.5M to $2.32B »

The Department of Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

GEMP

Gemphire Therapeutics

$9.54

-0.08 (-0.83%)

08:40
10/19/17
10/19
08:40
10/19/17
08:40
Initiation
Gemphire Therapeutics initiated  »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$37.97

0.48 (1.28%)

08:39
10/19/17
10/19
08:39
10/19/17
08:39
Recommendations
eBay analyst commentary  »

eBay progress…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$98.04

1.18 (1.22%)

08:39
10/19/17
10/19
08:39
10/19/17
08:39
Hot Stocks
Genuine Parts announces two industrial and automotive acquisitions »

Genuine Parts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 30

    Oct

BANR

Banner Corp.

$61.29

0.54 (0.89%)

, PUB

People's Utah Bancorp

$32.85

0.2 (0.61%)

08:38
10/19/17
10/19
08:38
10/19/17
08:38
Conference/Events
People's Utah Bancorp to hold a conference call »

Management discusses…

BANR

Banner Corp.

$61.29

0.54 (0.89%)

PUB

People's Utah Bancorp

$32.85

0.2 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 26

    Oct

  • 09

    Nov

MTG

MGIC Investment

$13.54

0.43 (3.28%)

08:37
10/19/17
10/19
08:37
10/19/17
08:37
Recommendations
MGIC Investment analyst commentary  »

MGIC Investment price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$153.00

2.62 (1.74%)

08:37
10/19/17
10/19
08:37
10/19/17
08:37
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

IFMK

iFresh

$12.15

-0.1 (-0.82%)

08:37
10/19/17
10/19
08:37
10/19/17
08:37
Hot Stocks
iFresh announces exclusive agreement with Dragon Seeds »

iFresh announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$7.00

-0.05 (-0.71%)

08:36
10/19/17
10/19
08:36
10/19/17
08:36
Technical Analysis
Technical View: Corbus Pharmaceuticals surges on anabasum Phase 2 results »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.